Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News InVivo Therapeutics Holdings Corp NVIVQ

Healthcare Medical Devices
InVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries (SCIs). The Company's Neuro-Spinal Scaffold implant is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. It is intended to promote appositional, or side-by... see more

Recent & Breaking News (OTCPK:NVIVQ)

InVivo Therapeutics Reports 2016 Second Quarter Financial Results and Business Update

Business Wire August 4, 2016

InVivo Therapeutics Announces Ben Taub Hospital/Baylor College of Medicine as New Site for INSPIRE Study

Business Wire July 18, 2016

InVivo Therapeutics Opens First Ex-U.S. Site in Canada for INSPIRE Study

Business Wire July 14, 2016

InVivo Therapeutics Receives Investigational Testing Authorization from Health Canada

Business Wire July 13, 2016

InVivo Therapeutics Announces Update on the INSPIRE Study and FDA Approval of Expansion of the Study to 20 Evaluable Patients

Business Wire July 12, 2016

InVivo Therapeutics to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference

Business Wire July 8, 2016

InVivo Therapeutics to Present at 34th Annual Symposium of the National Neurotrauma Society

Business Wire June 23, 2016

InVivo Therapeutics Announces Publication in Neurosurgery of Case Report Detailing First Neuro-Spinal Scaffold™ Implantation

Business Wire June 22, 2016

InVivo Therapeutics Announces Appointment of Christina Morrison to its Board of Directors

Business Wire June 8, 2016

InVivo Therapeutics Featured on CBS Radio Affiliate

Business Wire May 26, 2016

InVivo Therapeutics Announces Notice of Allowance for Patent Covering Methods of Treating Spinal Cord Injuries Using a Broad Array of Polymeric Implants, Including the Neuro-Spinal Scaffold™

Business Wire May 18, 2016

InVivo Therapeutics Announces Hospital of the University of Pennsylvania as New Site for INSPIRE Study

Business Wire May 11, 2016

InVivo Therapeutics Reports 2016 First Quarter Financial Results and Business Update

Business Wire May 6, 2016

InVivo Therapeutics Announces Symposium at 84th American Association for Neurological Surgeons Annual Scientific Meeting

Business Wire May 2, 2016

InVivo Therapeutics Reports Conversion of a Fourth Patient Implanted with the Neuro-Spinal Scaffold(TM) in the INSPIRE Study

Business Wire April 26, 2016

InVivo Therapeutics to Present at Committee Roundtable on Biomedical Engineering Materials and Applications

Business Wire April 20, 2016

InVivo Therapeutics Expresses Condolences on Death of Eighth Patient Enrolled in INSPIRE Study

Business Wire April 19, 2016

InVivo Therapeutics Announces John A. McCarthy, Jr. to Not Stand for Re-election

Business Wire April 12, 2016

InVivo Therapeutics Announces University of Virginia Health System as New Site for INSPIRE Study

Business Wire April 5, 2016

InVivo Therapeutics Featured in Life Science Leader

Business Wire April 4, 2016